References
- Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. 2014. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2:CD002252.
- Barton JR, Hiett AK, Conover WB. 1990. The use of nifedipine during the postpartum period in patients with severe preeclampsia. American Journal of Obstetrics and Gynecology 162:788–792.
- Dhali B, Bhattacharya S, Ganguly RP, Bandyopadhyay S, Mondal M, Dutta M. 2012. A randomized trial of intravenous labetalol & oral nifedipine in severe pregnancy induced hypertension. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 1:42–46.
- Easterling TR. 2014. Pharmacological management of hypertension in pregnancy. Seminars in Perinatology 38:487–495.
- Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. 2014. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 121:1210–1218.
- Jim B, Sharma S, Kebede T, Acharya A. 2010. Hypertension in pregnancy: a comprehensive update. Cardiology in Review 18:178–189.
- Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNIFPA and the World Bank. Geneva, World Health Organization; 2007
- Roberts JM, August PA, Bakris G, Barton JR, Bernstein IM, Druzin M, et al. 2013. Hypertension in Pregnancy Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics & Gynecology 122:1122–1131.
- Redman CW. 2011. Hypertension in pregnancy: the NICE guidelines. Heart 97:1967–1969.
- Raheem IA, Saaid R, Omar SZ, Tan PC. 2012. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG: An International Journal of Obstetrics & Gynaecology 119:78–85.
- Scardo JA, Vermillion ST, Hogg BB, Newman RB. 1996. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. American Journal of Obstetrics & Gynecology 175:336–338.
- Magee LA, Miremandi S, Li J, Cheng C, Ensom MH, Carleton B, et al. 2005. Therapy with both magnesium sulphate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. American Journal of Obstetrics & Gynecology 193:153–163.
- Shekhar S, Gupta N, Kirubakaran R, Pareek P. 2016. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology 123:40–47.
- Shekhar S, Sharma C, Thakur S, Verma S. 2013. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstetrics & Gynaecology 122:1057–1063.
- Vermillion ST, Scardo JA, Newman RB, Chauhan SPJ. 1999. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. American Journal of Obstetrics & Gynecology 181:858–861.